References
- AbESTT Investigators. Effects of abciximab for acute ischemic stroke: final results of abciximab in emergent stroke treatment trial (AbESTT). Stroke 2003; 34: 253
- Adams H, Hacke W, Blumki E, Clarke W, Hansen MD, LeClerc J. Adjusting favorable outcomes following treatment of acute ischemic stroke as influenced by baseline severity of neurological impairments. Cerebrovasc Dis 2003; 16: 52
- Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, , for the Second European-Australasian Acute Stroke Study Investigators, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 1998; 652: 1245–1251
- Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, , for the GAIN International Investigators, et al. Glycine antagonist gavestinel in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. Lancet 2000; 355: 1949–1954
- Lees KR, Hankey GJ, Hacke W. Design of future acute-stroke treatment trials. Lancet Neurol 2003; 2: 54–61
- Machado SG, Murray GD, Teasdale GM. Evaluation of designs for clinical trials of neuroprotective agents in head injury. J. Neurotrauma 1999; 16: 1131–1138
- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–1587
- Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999; 30: 1538–1541
- Wilson JTL, Hareendran A, Grant M, Baird T, Schulz UGR, Muir KW, Bone I. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin scale. Stroke 2002; 33: 2243–2246
- Young FB, Lees KR, Weir CJ, for the Glycine Antagonist in Neuroprotection (GAIN) International Steering Committee and investigators. Strengthening acute stroke trials through optimal use of disability end points. Stroke 2003; 34: 2676–2680
- Lees KR, Zivia JA, Ashwood T, , for the SAINT I Trial Investigators, et al. NXY-059 for acute ischemic stroke. N Engl J Med 2006; 354: 588–600